NG2-expressing pericytes are disorganized in the cardiac vasculature of <i>Pdgfd</i>^<i>-/-</i> mice. by Hanna Gladh (2586991)

“…(E-G, I-K and M-O) Representative images of PECAM and NG2 staining showing decreased expression of NG2 and altered morphology of NG2-expressing pericytes in <i>Pdgfd</i>^<i>-/-</i> (n = 4) hearts compared with wildtype hearts (n = 4). …”

Long-lived acceptor dark states can produce bimodal FRET efficiency distributions, multi-exponential donor excited-state decays, and a decrease in measured average FRET efficiency... by Steven S. Vogel (299330)

VANGL2 recruits NLRP3 to OPTN for selective autophagic degradation. by Huaji Jiang (16907514)

Optimized parameters for mesopic and photopic condition used in the study. by C. Vijay Reena Durai (14498259)

Subjects:

Binocular summation ratio. by C. Vijay Reena Durai (14498259)

Subjects:

Bland-Altman type plots of intersession difference. by C. Vijay Reena Durai (14498259)

Subjects:

Two Microsoft excel spreadsheets containing the raw data of the study have been added as supporting information. by C. Vijay Reena Durai (14498259)

Subjects:

Representation of better of the two eyes’ monocular FMTs and binocular FMTs. by C. Vijay Reena Durai (14498259)

Subjects:

Fig 7 - by C. Vijay Reena Durai (14498259)

Subjects:

S1 File - by C. Vijay Reena Durai (14498259)

Subjects:

Representation of better of the two eyes’ monocular FMTs and binocular FMTs. by C. Vijay Reena Durai (14498259)

Subjects:

Fig 1 - by C. Vijay Reena Durai (14498259)

Subjects:

Distinct expression patterns of <i>Bgl-</i>FaNaC and the FMRF-NH₂ precursors in the visceral and left parietal ganglia. by Laura C. Vicente-Rodríguez (16437803)

The effect of NaCl on frozen α₂M preparations. by Amy R. Wyatt (759221)

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

Subjects:

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Subjects:

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Subjects:

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

Subjects: